Crossmark

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma

Crossref DOI link: https://doi.org/10.15252/emmm.201809081

Published Online: 2019-01-04

Published Print: 2019-02

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Chua, Vivian https://orcid.org/0000-0002-1873-6820
Orloff, Marlana

Teh, Jessica LF

Sugase, Takahito

Liao, Connie

Purwin, Timothy J

Lam, Bao Q

Terai, Mizue

Ambrosini, Grazia

Carvajal, Richard D

Schwartz, Gary

Sato, Takami

Aplin, Andrew E https://orcid.org/0000-0002-2734-3244
Funding

Funding for this research was provided by:

American Association for Cancer Research (17‐40‐39‐CHUA)

National Cancer Center

Dr. Ralph and Marian Falk Medical Research Trust

Melanoma Research Alliance

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
License Information

Version of Record valid from 2019-01-04
More Information

Publication History

Received: 2018-03-06

Accepted: 2018-12-11

Published: 2019-01-04